Precision Medicine News and Research

RSS

MGI Partners with ALACRiS Theranostics to Open New Customer Experience Center in Germany

MGI, a company committed to building core tools and technology to lead life science, today announced the launch of its new Customer Experience Center (CEC) in Berlin, Germany.

From MGI 8 Nov 2022

Researchers provide insights on how to overcome resistance in cancer therapy

The latest developmental drugs, particularly for the use in oncology, rely on the targeted degradation of harmful pathogenic proteins.

3 Nov 2022

Novel computational method maps the architecture of human tissues in unprecedented detail

Weill Cornell Medicine researchers have developed a computational method to map the architecture of human tissues in unprecedented detail. Their approach promises to accelerate studies on organ-scale cellular interactions and could enable powerful new diagnostic strategies for a wide range of diseases.

1 Nov 2022

The impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosis

A new study aimed to analyze the association between lifestyle risk factors, PRSs, and their interactions along with the risk of CVE within 90 days post-COVID-19 diagnosis.

31 Oct 2022

New diagnostic method applies machine learning to advanced genomics data to detect sepsis

Sepsis, the overreaction of the immune system in response to an infection, causes an estimated 20% of deaths globally and as many as 20 to 50% of U.S. hospital deaths each year.

24 Oct 2022

New machine learning model can screen novel drug compounds to accurately predict efficacy in humans

The journey between identifying a potential therapeutic compound and Food and Drug Administration approval of a new drug can take well over a decade and cost upwards of a billion dollars.

18 Oct 2022

Total body PET/CT scans can effectively visualize systemic joint involvement in patients with arthritis

Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of The Journal of Nuclear Medicine.

14 Oct 2022

Study identifies regional differences in women with polycystic ovary syndrome

The environment could be playing a critical role in the expression of polycystic ovary syndrome (PCOS) in women living in Alabama, as compared to women in California, according to a new study published in the Journal of Clinical Endocrinology & Metabolism.

12 Oct 2022

Study finds geographical differences in PCOS symptoms among black and white women

Women with polycystic ovary syndrome (PCOS) in Alabama may be more likely to have excessive hair growth and insulin resistance, whereas women with PCOS in California may be more likely to have higher testosterone levels, according to new research published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

11 Oct 2022

CMU Array holds potential to transform how doctors treat neurological disorders

Carnegie Mellon University researchers have pioneered the CMU Array - a new type of microelectrode array for brain computer interface platforms.

5 Oct 2022

New project secures NIH funding to tackle chronic health disparities

Chronic diseases such as diabetes, heart disease and cancer disproportionally affect racial and ethnic minorities.

5 Oct 2022

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

New research from the University of Cincinnati bolsters a hypothesis that Alzheimer's disease is caused by a decline in levels of a specific protein, contrary to a prevailing theory that has been recently called into question.

5 Oct 2022

Universal vaccine advancement through AI and recombinant technology

In this interview, News-Medical talks to Dr. Amy Sheng and Dr. Lurong Pan about how AI computing can be used in combination with high throughput production and screening to enhance the development process for potential universal vaccines.

From Sino Biological Inc. 3 Oct 2022

Breath tests can lead to more personalized therapies for IBS patients

A new study led by Cedars-Sinai investigators found using breath tests to identify gut gas profiles can potentially help lead to more personalized therapies for people diagnosed with irritable bowel syndrome (IBS).

30 Sep 2022

uPAR may be a promising target for therapy in patients with neuroendocrine neoplasms

A novel PET radiotracer can accurately assess the presence of a biomarker that indicates the level of tumor aggressiveness in neuroendocrine neoplasms (NENs).

28 Sep 2022

One-time test predicts which hospitalized COVID-19 patients are likely to worsen, study finds

A one-time test could predict which people hospitalized with COVID-19 are likely to worsen significantly during their stay, even if they were admitted with relatively mild symptoms, according to a study of more than 2,500 people headed by researchers at Stanford Medicine.

27 Sep 2022

New lab technique could spark a 'paradigm shift' in testing protein-based drugs

New Jersey Institute of Technology researchers have unveiled a new lab technique they say represents a "paradigm shift" in how pharmaceutical laboratories test and produce new protein-based drugs, such as therapeutic monoclonal antibodies being developed to treat a variety of diseases, from cancers to infectious diseases.

27 Sep 2022

Leducq Foundation awards $15 million to advance the understanding of atherosclerosis

The Leducq Foundation has awarded $15 million to researchers at UVA Health and their collaborators to advance our understanding of atherosclerosis, or hardening of the arteries, and find better ways to treat it. Diseases linked to atherosclerosis are the leading cause of death in the United States.

27 Sep 2022

Designing a new treatment to treat migraine effectively

In this interview, we speak to Mudra Kapoor, Vice President of Global Medical Affairs for Neuroscience at AbbVie, about atogepant, their new treatment option for migraine.

From AbbVie 26 Sep 2022

Genome editing approaches enable precise gene correction and disease rescue in inherited retinal diseases

In a new paper, University of California, Irvine researchers explain how precision genome editing agents have enabled precise gene correction and disease rescue in inherited retinal diseases (IRDs).

23 Sep 2022

Precision Medicine News and Research

MGI Partners with ALACRiS Theranostics to Open New Customer Experience Center in Germany

Researchers provide insights on how to overcome resistance in cancer therapy

Novel computational method maps the architecture of human tissues in unprecedented detail

The impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosis

New diagnostic method applies machine learning to advanced genomics data to detect sepsis

New machine learning model can screen novel drug compounds to accurately predict efficacy in humans

Total body PET/CT scans can effectively visualize systemic joint involvement in patients with arthritis

Study identifies regional differences in women with polycystic ovary syndrome

Study finds geographical differences in PCOS symptoms among black and white women

CMU Array holds potential to transform how doctors treat neurological disorders

New project secures NIH funding to tackle chronic health disparities

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

Universal vaccine advancement through AI and recombinant technology

Breath tests can lead to more personalized therapies for IBS patients

uPAR may be a promising target for therapy in patients with neuroendocrine neoplasms

One-time test predicts which hospitalized COVID-19 patients are likely to worsen, study finds

New lab technique could spark a 'paradigm shift' in testing protein-based drugs

Leducq Foundation awards $15 million to advance the understanding of atherosclerosis

Designing a new treatment to treat migraine effectively

Genome editing approaches enable precise gene correction and disease rescue in inherited retinal diseases

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News